Merck KGaA (OTCMKTS:MKKGY) Hits New 12-Month Low – Should You Sell?

Shares of Merck KGaA (OTCMKTS:MKKGYGet Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $28.82 and last traded at $28.88, with a volume of 139018 shares traded. The stock had previously closed at $29.22.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group assumed coverage on shares of Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating for the company.

View Our Latest Analysis on MKKGY

Merck KGaA Stock Down 1.2 %

The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $18.66 billion, a P/E ratio of 17.83, a PEG ratio of 2.37 and a beta of 0.93. The company has a fifty day moving average price of $31.74 and a 200-day moving average price of $34.31.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.